Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 07, 2022 07:30 ET | Source: Dave & Buster's Entertainment, Inc.

Dave & Buster’s Reports Record First Quarter 2022 Financial Results

DALLAS, June 07, 2022 (GLOBE NEWSWIRE) -- Dave & Buster's Entertainment, Inc., (NASDAQ:PLAY), ("Dave & Buster's" or "the Company"), an owner and operator of entertainment and dining venues,...
June 07, 2022 07:30 ET | Source: Sophos Inc.

Attacker Dwell Time Increased by 36%, Sophos’ Active Adversary Playbook 2022 Reveals

Increase is Due to Exploitation of ProxyLogon and ProxyShell Vulnerabilities, Plus Initial Access Brokers Despite a Drop in Remote Desktop Protocol Use for External Access, Attackers...
June 07, 2022 07:29 ET | Source: Orion Energy Systems, Inc.

Orion Energy Systems Reports FY 2022 Revenue of $124.4M, EPS of $0.19, Gross Profit Percentage of 27.3% and over $35M of Liquidity

MANITOWOC, Wis., June 07, 2022 (GLOBE NEWSWIRE) -- Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting and control systems, including turnkey...
June 07, 2022 07:23 ET | Source: Research and Markets

30th Aircraft Leasing Conference: Commercial, Legal and Technical Issues - London , United Kingdom - June 24th, 2022

Dublin, June 07, 2022 (GLOBE NEWSWIRE) -- The "Aircraft Leasing: Commercial, Legal and Technical Issues" conference has been added to ResearchAndMarkets.com's offering. Further to its previous...
June 07, 2022 07:00 ET | Source: Versus Systems Inc.

Versus Systems Announces Partnership with Experiential and Digital Marketing Agency Innovative Group

LOS ANGELES, June 07, 2022 (GLOBE NEWSWIRE) -- Versus Systems Inc. (“Versus” or the “Company”) (Nasdaq: VS) today announced that the Company has entered into a strategic partnership with...
June 07, 2022 07:00 ET | Source: ASLAN PHARMACEUTICALS LIMITED

ASLAN Pharmaceuticals Initiates Scientific Collaboration to Investigate the Distinct Role of IL-13 Receptor Signaling in Atopic Dermatitis

MENLO PARK, Calif. and SINGAPORE, June 07, 2022 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative...
June 07, 2022 06:33 ET | Source: Research and Markets

Worldwide Cold Insulation Industry to 2026 - Europe Dominates Consumption, While China Leads Global Growth in Demand

Dublin, June 07, 2022 (GLOBE NEWSWIRE) -- The "Cold Insulation - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Insulation refers to a material...
June 07, 2022 04:55 ET | Source: ReportLinker

Functional Foods and Beverages: Global Markets

New York, June 07, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Functional Foods and Beverages: Global Markets" -...
June 07, 2022 01:30 ET | Source: OSE Immunotherapeutics

Four Poster Presentations at 2022 ASCO Annual Meeting

NSCLC Atalante-1 Phase 3 Trial Beyond Checkpoint Inhibitor Neoepitope Specific Immunotherapy Tedopi® Shows Significant Patient-Reported Outcomes Versus ChemotherapyPositive Interim Results in Phase 2...
June 06, 2022 20:13 ET | Source: Junshi Biosciences

Junshi Biosciences Highlights Pipeline Advances in Immuno-Oncology Through Nearly 40 Data Presentations of Icatolimab and Toripalimab at ASCO 2022

--Favorable preliminary safety and efficacy data for anti-BTLA monoclonal antibody, icatolimab, for the treatment of lymphoma and solid tumors --Toripalimab continues to demonstrate synergy as...